Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • M&A

Chimerix Announces Closing Of TEMBEXA Sale To Emergent BioSolutions; $238M In Upfront Payment Received At Closing With Additional $136.5M In Potential Milestone Payments Plus Royalties

By Benzinga Newsdesk
Today, 6:07 AM
DURHAM, N.C., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Chimerix, Inc. (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing

CMRX

Read More
1 minute read
  • News

European Union Drug Regulator European Medicines Agency Says Monkeypox Infection Trend Gives Hope That The Outbreak Can Be Contained

By Benzinga Newsdesk
Today, 6:07 AM
- Reuters 

AEMD

Read More
2 minute read
  • Biotech
  • General
  • News

Earlier Announced: China Records First Monkeypox Case

By Benzinga Newsdesk
Today, 6:07 AM
https://www.scmp.com/news/china/science/article/3192823/china-records-first-monkeypox-case?utm_term=Autofeed&utm_medium=Social&utm_content=article&utm_source=Twitter#Echobox=1663339580 The infected patient, who had arrived in Chongqing from overseas, developed symptoms while in Covid quarantine

AEMD

Read More
1 minute read
  • News

White House Says New Monkeypox Cases Down 50% Since Early August

By Benzinga Newsdesk
Today, 6:07 AM
- Reuters 

AEMD

Read More
13 minute read
  • Analyst Ratings
  • Downgrades
  • Initiation
  • Intraday Update
  • Upgrades

Benzinga’s Top Ratings Upgrades, Downgrades For September 7, 2022

By Benzinga Insights
Today, 6:07 AM
Upgrades

ACCD

Read More
1 minute read
  • News

White House Seeks $44.5B To Fight COVID And Monkeypox, Aid Ukraine; Biden Administration To Request From Congress $22.4B For COVID-19, $4.5B For Monkeypox, $6.5B For Natural Disaster Relief

By Bill Haddad
Today, 6:07 AM
-Reuters

AEMD

Read More
1 minute read
  • General
  • News
  • Politics

White House Seeks $44.5 Billion To Fight Covid And Monkeypox, Aid Ukraine – Wall Street Journal

By Benzinga Newsdesk
Today, 6:07 AM
- Dow Jones

AEMD

Read More
1 minute read
  • News

Belgium Reports 1st Monkeypox Death

By Benzinga Newsdesk
Today, 6:07 AM
- BNO News https://twitter.com/BNOFeed

AEMD

Read More
6 minute read
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

Why Bed Bath & Beyond Jumped Around 25%; Here Are 68 Biggest Movers From Yesterday

By Lisa Levin
Today, 6:07 AM
Gainers

AAPL

Read More
1 minute read
  • Contracts
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Why Chimerix Stock Is Soaring Today

By Adam Eckert
Today, 6:07 AM
Chimerix Inc (NASDAQ: CMRX) shares are trading higher Monday after the company won a multi-year contract with the Biomedical Advanced Research and Development Authority (BARDA) in the U.S. Department of Health and Human Services' Administration for Strategic Preparedness and Response.

CMRX

Posts navigation

Previous 1 2 3 … 15 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service